Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another

·4 min read
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another

Cathie Wood believes in the potential of gene editing. It's not surprising that Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) and ARK Innovation ETF (NYSEMKT: ARKK) have invested heavily in several gene-editing stocks. The ARK Innovation ETF recently sold some of its shares of Editas Medicine (NASDAQ: EDIT).

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting